Minnesota Is the Model, and the Industry Is Not Ready to Live Up to It
Kemal WhyteTwo states moved on the same substance inside the same two weeks, and they moved in opposite directions. One of those moves has been covered everywhere. The other is the one that actually matters, and I have barely seen it mentioned.
North Dakota prohibited kratom outright. Executive Order 2026-04 took effect at 5 p.m. on 5 August 2026, it reaches sale, purchase and possession, and it arrived with roughly 48 hours of notice and no vote in front of it. The order is temporary. It runs 30 days and lapses around 4 September 2026, Governor Armstrong has called a special legislative session for 2 September 2026 to decide whether prohibition goes into statute, and a separate Board of Pharmacy emergency rule has scheduled 7-OH as a controlled substance for about 180 days, which outlasts the order that got all the coverage. Minnesota raised the legal age to purchase and possess kratom from 18 to 21. That took effect on 1 August 2026, after a bill that cleared the House 127 to 5 and the Senate 56 to 10, was signed by the governor on 5 May 2026, and gave every shop in the state about three months to organize itself before the rule bit.
On 4 August I argued that the venue where this gets decided has moved from legislatures to governors' offices, and that the industry was watching the wrong door. I stand by that. I also did not write a word about Minnesota, which is precisely the failure I was describing in everybody else, so let me correct it here.
Minnesota is the model. It is procedurally dull, it produced almost no coverage next to the ban, and it is the single best piece of news this category has had all year. The uncomfortable part, the one I would rather not put in writing, is that the industry cannot currently deliver what Minnesota just asked of it.
What Minnesota actually did
HF 3453, sponsored by Rep. Jessica Hanson (DFL-Burnsville), and its Senate companion SF 3704, raised the age to purchase and possess kratom from 18 to 21. Selling to anyone under 21 is a gross misdemeanor. Possession by anyone under 21 is a misdemeanor. The change sits in Minn. Stat. Sec. 152.027, the other controlled substance offenses section. What the amendment did not do is touch the penalties. It struck 18, wrote 21 and stopped. Those offense levels are the same ones that applied at 18, so if you have read that Minnesota got tougher on sellers, you have read something written by somebody who did not open the bill.
Read what it does not do, because that is where the trade press will get this wrong. It is not a ban. Kratom remains legal to sell to adults of 21 and over in Minnesota, on the same shelves, through the same accounts. It is not a scheduling action, and kratom is not a controlled substance in that state. The Minnesota Department of Health does not regulate the sale or possession of it, so there is no state license, no testing standard and no labeling regime attached to the change. One number moved from 18 to 21. Everything else stayed exactly where it was.
The governor's office announced it inside a list of nine bills signed on 5 May 2026. The subtitle of that release flags a memorial highway designation and consumer protections on cryptocurrency kiosks. Kratom is the second line item, one sentence long. That is not a complaint. It is the point: a rule this industry has publicly asked states to adopt for a decade went through so quietly that the governor's own communications team did not think it was worth the headline.
FOX 9 in Minneapolis did cover it properly, on 23 July 2026, more than a week ahead of the effective date, which is better than most outlets managed and better than I managed. Beyond that the volume was close to nothing. Compare it with the wall of coverage North Dakota generated in two days and you get a clean illustration of what the press is actually rewarding, which is not good policy.
The vote is the part nobody looked at
127 to 5. 56 to 10.
Sit with those two lines, because I think they are the most useful numbers published about this category all year. In a legislature that struggled to agree on a great deal else in the 2026 session, an age restriction on kratom drew five no votes in the House and ten in the Senate. That is not a contested policy. That is a policy nobody had to be talked into, carried by members who in most cases had no particular view on the plant and simply recognized an age limit as an obviously reasonable thing to ask for.
Now set it against North Dakota. Lawmakers there declined to prohibit a kratom compound in 2025, took up a regulation bill instead, amended that into a recommendation for a study, and then never pursued the study. Three passes through the front door across two sessions, three refusals to prohibit, and then the executive branch reached the opposite outcome in a morning. The legislature does get its say. It gets it on 2 September 2026, in a special session called after the ban was already running, which makes it a vote to ratify rather than a vote to decide. That distinction is the one I want operators to hold on to. The order did not replace the vote. It got in front of it, and a legislature asked to bless a prohibition already in force is in a very different position from one asked to impose it.
The lesson is not that legislatures are friendly. It is narrower and more useful than that. Legislatures will pass an age limit almost without argument, and they will not pass a comprehensive framework without a fight, and if this industry only ever shows up asking for the hard thing it leaves the easy thing sitting on the table. The easy thing is the one that keeps a market open.
Notice is the part of a rule that decides who survives it
From signature on 5 May 2026 to effect on 1 August 2026 is 88 days. North Dakota gave about two.
Eighty-eight days is enough to do the work. You can relabel. You can retrain a counter, write the script, put the sign up and check that people are using it. You can reconfigure a checkout, add a verification step, and watch what it does to your conversion rate before it is legally compulsory. You can call every wholesale account in the state, tell them what is changing, and sell through the stock that is going to be awkward while it is still perfectly lawful to sell it. You can, if you are honest with yourself, find out that your own age gate is a decoration and replace it.
Forty-eight hours is enough to send an email. That is the whole list.
The difference between those two numbers is the difference between a rule and a seizure, and it is not an accident of drafting. It is what a legislature produces and an emergency order structurally cannot. Every operator who complains that regulation is expensive should notice that the expensive part is almost never the requirement. It is the runway, or the absence of one. A rule you have three months to meet is a line item. The same rule with two days on it is a write-off, and I have watched businesses die of the second one while insisting they were killed by the first.
An age limit is the rule this industry keeps saying it wants
Every model bill the trade has put its name to over the last decade carries an age restriction. Twenty-one is not a concession anyone dragged us to. It is a line the industry drew itself, in its own drafts, and then spent years asking states to adopt.
States are adopting it. Rhode Island reopened in April 2026, the first state to reverse a kratom ban, and it reopened into four license classes with sales restricted to 21 and over, caps of 150 mg of mitragynine and 1 mg of 7-OH per serving, heavy-metal limits and packaging rules. New York has required 21 and warning labels since December 2025. Texas and Florida have their own versions, arrived at by different routes. The National Conference of State Legislatures has been tracking the whole spread, and its read is that lawmakers are weighing guardrails against outright bans, which is a fair description of the fork this category is standing at and a fairly generous one.
So when a state does the thing the industry asked for, and does it 127 to 5, the correct response is not silence and it is certainly not a press release about how misunderstood we all are. It is to say yes, that is the rule, we asked for it, and here is how we make it real.
I do not know how many operators testified in St. Paul this session. I suspect the honest answer is close to none, because I did not, and nobody organizing the effort asked me to. That is a failure with my name on it as much as anyone's.
The uncomfortable part, which is ours
Here is where I stop being pleased with anybody, including myself.
An age limit is only a rule if somebody enforces it, and much of this category does not. The dominant form of age verification on kratom websites is a box you click that says you are over 21. That is not verification. It is a piece of theater that exists to create a record, and every person who has ever built one knows it. I have looked at the sites my own companies run and they are inside this criticism. Writing that sentence is unpleasant and I am leaving it in, because a column that assigns the failure entirely to other people would not be worth your time and you would smell it immediately.
Retail is worse, in a different way. A great deal of this product moves through gas stations and smoke shops where nobody is carded for anything that is not tobacco or alcohol, where the person behind the counter has had no training on what the bottle contains, and where the product sits at eye level next to the energy drinks because that is where it sells. Minnesota has attached a gross misdemeanor to selling under 21. It has not attached an inspector, a license you can lose, or a test purchase program to go with it, because it did not build a licensing regime to hang those things on. Enforcement in practice will be complaint-driven. Which means that for a lot of Minnesota retailers, the first time they find out the age changed will be when somebody with a badge is standing on the other side of the counter.
If this industry treats 21 as a compliance sticker, the outcome is not that we get away with it. The outcome is North Dakota. Officials do not reach for emergency powers over a category that visibly polices itself. They reach for them when the picture in front of them is a product sold beside a fizzy drink with no age check, no consistent labeling, and potency that varies by an order of magnitude between two packages that look identical. I wrote that on 4 August about North Dakota. Minnesota is the reason to say it again, and to say it harder: we have just been handed the version of this we claim to want, and if we do not make the age real at the counter, the next state will skip the age bill entirely and go straight to the order.
What is in the bottle does not follow from what is on the front
There is a second thing in Minnesota's drafting that almost nobody in the trade has recognized, and I think it matters more than the age itself.
The statute reaches kratom or a substance that contains mitragynine or 7-hydroxymitragynine. It attaches to the compound, not to the marketing category. A drink with kava on the front of the bottle and mitragynine in the formula is covered by that language, whatever the label says and whatever the buyer thinks they are holding. So is anything else blended, extracted, flavored or rebranded into a shape that does not read as kratom on a shelf.
I am going to make that case from public documents, because it does not need anything else. In July 2025 the FDA sent warning letters to companies selling food and beverage products that contained concentrated 7-OH, on the ground that the ingredient cannot lawfully be added to conventional food. Read what that tells you about shelves. Concentrated 7-OH had already been formulated into ordinary drinks and snacks and sold as food, at enough scale for the FDA to write to the companies doing it.
Then, on 6 July 2026, the DEA filed to place 7-OH and three related derivatives into temporary scheduling while leaving certain botanical kratom items outside the action. I have not seen confirmation that the final order has issued, so I am not going to write about it as though it had. What I will take from it is the shape, because the shape is the same lesson twice from two different agencies: the thing being chased is a compound, and a compound does not care what the category on the front of the package says.
Which puts a Minnesota retailer in a specific position. If you decide the new age limit does not reach a given shelf because the front of the bottle says kava, you have made a legal judgment on the basis of a marketing decision. That is not a defense. It is a guess wearing a defense's clothes.
The fix is not complicated and it is not cheap. Assay the product. Know the mitragynine and 7-OH content of every SKU you sell as a number you can produce on demand rather than a claim you can gesture at. Then age-gate on the basis of what is in it, not what it is called. Yes, that is a real cost, and yes, it lands hardest on the smallest operators, which is the honest objection and one I do not have a comfortable answer to. It is still a smaller cost than a gross misdemeanor and a very much smaller cost than a state deciding the whole category is unmanageable.
Minnesota did not finish the job either
I do not want to oversell this. Minnesota raised an age and did nothing else.
There is no licensing regime. No testing standard, no potency cap, no labeling rule, no heavy-metal limit, no requirement that a package tell a buyer what is inside it in any form they could check. The Department of Health does not regulate sale or possession, which means there is no agency whose job this is. So what Minnesota has now is an age gate on a product nobody is required to measure. That is better than what it had. It is a long way short of what Rhode Island built, and it leaves the state one bad news cycle away from somebody arguing that the age limit was tried and did not work.
Let me summarize it the way I would to a buyer rather than to a reporter. Minnesota got the venue right, got the direction right, and stopped early. Rhode Island got the venue right and went the distance, at a price most of this industry has not accepted yet. North Dakota took the outcome first and left the venue until 2 September 2026, which is a vote to ratify rather than a vote to decide. Ranked by where I would prefer to be operating in three years, that is the order, and the gap between first and third is not close.
What I would actually do with this
If you sell, replace the checkbox. A real verification step online, an identity check or a third-party service at the point of purchase rather than an attestation, and a carding rule at retail that your staff can recite back to you without looking it up. It will cost you sales. Some of those lost sales will be adults who could not be bothered, and that is genuinely painful in a low-margin category. Price it in and do it anyway, because the alternative is not the status quo. The alternative is a governor's signature.
Second, know your alkaloid content by SKU and gate on the compound rather than the category. If your team cannot tell you within five minutes whether a given product contains mitragynine, you cannot answer a Minnesota question, and you certainly cannot answer a North Dakota one.
Third, go and testify where the age bills are, not only where the ban bills are. Age bills pass 127 to 5. They move early in a session, they attract almost no organized opposition, and almost nobody from this industry turns up to help write them. That is the cheapest and most effective lobbying available in this country and it is sitting unclaimed while everyone fights the fires.
If you buy, check your own state against the state itself rather than against a tracker, because several national trackers were wrong about Rhode Island for months after it reopened and they will be slower on this, not faster. In Minnesota the rule is simple enough to hold in your head: 21 to buy, 21 to possess, and a shop that sells to you under 21 is committing a gross misdemeanor rather than doing you a favor. If you have a poisoning concern, the Minnesota Regional Poison Center is on 1-800-222-1222, and it is 911 if somebody needs care immediately.
One thing I will not do is dress this up as a health story with a happy ending inside it. Kratom is not a treatment for opioid use disorder and it is not a treatment for withdrawal, whatever anybody tells you across a counter. The medicines that treat those are buprenorphine, methadone and naltrexone, and a person who needs them should be talking to a clinician and not to a retailer. I sell botanical products for a living. I am not going to make a medical claim about them to win an argument about age limits.
I keep the state map and bill tracker on the industry intel page, and Minnesota is on it. The 4 August column on North Dakota has the executive order detail if you need the other half of this comparison, and the July update has the federal threshold and the leaf versus concentrate split that most of this hangs off.
It will be wrong eventually, because this is moving faster than anything I publish. When you are making a decision with money attached, verify with a lawyer in that jurisdiction. I mean that as advice rather than as a disclaimer. And if you run a shop in Minnesota, go and look at your own age gate before somebody else does it for you.
Disclaimer: This article summarizes publicly reported legal developments as of 10 August 2026 and links to primary sources so you can check them yourself. It is general commentary, not legal advice, and it is not a substitute for counsel in your jurisdiction. Laws in this area change quickly and local rules may differ from state rules. Nothing here is a health claim, and statements about botanical products have not been evaluated by the Food and Drug Administration.